Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Stem cell therapy may help treat tough hair loss cases.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Personality traits and anxiety affect hair loss patients' quality of life.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Lower BDNF levels link to worse depression in alopecia areata patients.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Certain gene variations may increase the risk and severity of alopecia areata.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Triamcinolone acetonide is more effective than cryotherapy for hair regrowth in alopecia areata but has different side effects.

Ayurvedic treatment successfully regrew hair in a 19-year-old with alopecia areata in 2 months.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Unani medicine may help treat a rare, hard-to-treat hair loss pattern in children.

A combined treatment with microneedling and vitamin D3 led to complete hair regrowth in a woman with stubborn patch alopecia areata.